These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10555916)

  • 1. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma.
    Phan TG; Cass A; Gillin A; Trew P; Fertig N; Sturgess A
    J Rheumatol; 1999 Nov; 26(11):2489-92. PubMed ID: 10555916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
    Bhavsar SV; Carmona R
    J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort.
    Emilie S; Goulvestre C; Bérezné A; Pagnoux C; Guillevin L; Mouthon L
    Scand J Rheumatol; 2011; 40(5):404-6. PubMed ID: 21623662
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
    Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
    J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis.
    Molina JF; Anaya JM; Cabrera GE; Hoffman E; Espinoza LR
    J Rheumatol; 1995 Mar; 22(3):557-60. PubMed ID: 7783082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
    Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
    J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
    Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
    Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma renal crisis.
    Bose N; Chiesa-Vottero A; Chatterjee S
    Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-RNA polymerase III antibodies in scleroderma renal crisis].
    Schorn R; Gaspert A; Cohen CD
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1118-21. PubMed ID: 20503137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of RNA polymerase III antibodies with scleroderma renal crisis.
    Nguyen B; Assassi S; Arnett FC; Mayes MD
    J Rheumatol; 2010 May; 37(5):1068; author reply 1069. PubMed ID: 20439528
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
    Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
    J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis.
    Bardoni A; Rossi P; Salvini R; Bobbio-Pallavicini F; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2003; 21(3):301-6. PubMed ID: 12846047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.
    Shanmugam VK; Steen VD
    Curr Opin Rheumatol; 2012 Nov; 24(6):669-76. PubMed ID: 22955019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
    Takada D; Hoshino J; Kikuchi K; Yabuuchi J; Kogure Y; Ueno T; Sekine A; Yamanouchi M; Sumida K; Mise K; Suwabe T; Hayami N; Sawa N; Takaichi K; Hayasi N; Fujii T; Ohashi K; Ubara Y
    Mod Rheumatol; 2018 Mar; 28(2):369-372. PubMed ID: 26942857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse alveolar haemorrhage in a case with anti-RNA polymerase III antibody-positive systemic sclerosis successfully treated with plasma exchange and corticosteroid therapy.
    Asai A; Banno S; Asai N; Ito M; Sugiyama H; Yamaguchi M; Iwagaitsu S; Nobata H; Kinasi H; Katsuno T; Ito Y
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):51-55. PubMed ID: 33086969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
    Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
    Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.
    Shah AA; Hummers LK; Casciola-Rosen L; Visvanathan K; Rosen A; Wigley FM
    Arthritis Rheumatol; 2015 Apr; 67(4):1053-61. PubMed ID: 25605296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of systemic sclerosis patients with anti-RNA polymerase III antibody in a single centre in Spain.
    Callejas-Moraga EL; Guillén-Del-Castillo A; Marín-Sánchez AM; Roca-Herrera M; Balada E; Tolosa-Vilella C; Fonollosa-Pla V; Simeón-Aznar CP
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):41-48. PubMed ID: 30767873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.